Axitinib Impurity IMYF, with the CAS number 1443118-71-5, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent axitinib, which is primarily used in cancer treatment, particularly for renal cell carcinoma. The characteristics of this impurity include its molecular structure, which is related to the parent compound, and it may exhibit similar physical and chemical properties, such as solubility and stability under various conditions. Impurities like IMYF are often characterized by their potential impact on the efficacy and safety of the drug formulation, necessitating thorough analysis during the drug development process. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are typically employed to identify and quantify such impurities. Understanding the characteristics of axitinib impurities is crucial for regulatory compliance and ensuring the quality of pharmaceutical products.

Axitinib Impurity IMYF

1443118-71-5: Axitinib Impurity IMYF, with the CAS number 1443118-71-5, is a chemical compound that is recognized as an impurity associated with the pharmaceutical agent axitinib, which is primarily used in cancer treatment, particularly for renal cell carcinoma. The characteristics of this impurity include its molecular structure, which is related to the parent compound, and it may exhibit similar physical and chemical properties, such as solubility and stability under various conditions. Impurities like IMYF are often characterized by their potential impact on the efficacy and safety of the drug formulation, necessitating thorough analysis during the drug development process. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are typically employed to identify and quantify such impurities. Understanding the characteristics of axitinib impurities is crucial for regulatory compliance and ensuring the quality of pharmaceutical products.

CAS 1443118-71-5

Axitinib Impurity IMYF

2-((3-Iodo-1H-indazol-6-yl)sulfinyl)-N-methylbenzamide

Ref: ST-EA-CP-A34057